XML 14 R5.htm IDEA: XBRL DOCUMENT
v3.23.1

Consolidated Statements of Comprehensive Loss Parentheticals - USD ($) $ in Thousands | 3 Months Ended
--- | ---
Mar. 31, 2023 | Mar. 31, 2022
Consolidated Statements of Operations [Abstract] |  |
Stock-based compensation expense associated with research and development expense | $ 1,203 | $ 1,032
Stock-based compensation expense associated with selling, general and administrative expense | $ 2,212 | $ 1,740

X
- Definition Consolidated Statements of Operations [Abstract] + References No definition available. + Details
Name: | lxrx_ConsolidatedStatementsOfOperationsAbstract
Namespace Prefix: | lxrx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock-based compensation expense included in research and development expense. + References No definition available. + Details
Name: | lxrx_StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpense
Namespace Prefix: | lxrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock-based compensation expense associated with selling, general and administrative expense + References No definition available. + Details
Name: | lxrx_Stockbasedcompensationexpenseassociatedwithsellinggeneralandadministrativeexpense
Namespace Prefix: | lxrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration